Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 09, 2019

SELL
$1.33 - $2.12 $16,625 - $26,500
-12,500 Closed
0 $0
Q1 2019

May 08, 2019

SELL
$1.57 - $2.71 $4,710 - $8,130
-3,000 Reduced 19.35%
12,500 $25,000
Q4 2018

Feb 07, 2019

BUY
$1.31 - $2.53 $3,930 - $7,589
3,000 Added 24.0%
15,500 $20,000
Q1 2018

May 15, 2018

BUY
$3.09 - $4.43 $1,545 - $2,215
500 Added 4.17%
12,500 $53,000
Q4 2017

Feb 14, 2018

BUY
$3.29 - $4.06 $39,480 - $48,719
12,000
12,000 $40,000

Others Institutions Holding NYMX

About NYMOX PHARMACEUTICAL CORP


  • Ticker NYMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,265,000
  • Market Cap $42.9M
  • Description
  • Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...
More about NYMX
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.